COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

Intermittent Catheterization Acceptance Test (I-CAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01651546
Recruitment Status : Completed
First Posted : July 27, 2012
Last Update Posted : June 15, 2015
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:

The aim of the study is to create and validate a specific test named Intermittent Catheterization Acceptance Test (I-CAT), assessing "the acceptance" of clean intermittent self catheterization (CISC) in a neurological and no neurological population with indication to self catheterization.

CISC avoids urological complications in bladder with chronic and improves quality of life. Despite theses challenges, the learning of CISC can face some physical, cognitive and psychological difficulties. Recently, we have validate a new test for predicting the physical and cognitive abilities to practice CISC named "PP-Test". Meanwhile, psychological factors are not explored in this test. To our knowledge, no study has been conducted in order to demonstrate in a prospective trial, which kind of psychological barriers can exist. Likewise it would be interesting to create a new test assessing the psychological "acceptance" of the patients to CISC before learning (I-CAT). Based on the results of this self-assessment test, the specific nurse could then change her speech by playing down the importance of some fear and anxiety described by the patients. The learning of CISC would be facilitated.

Condition or disease Intervention/treatment Phase
Intermittent Self Catheterization Behavioral: Intermittent catheterization test Not Applicable

Detailed Description:

The first version of the questionnaire (I-CAT) has already been elaborated from some neuro-urology experts and patients's comments.

The final version will be validated after a feasibility study. The psychometric criteria will be validated.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 200 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Development and Psychometric Validation of a Scale Assessing "the Acceptance" of Clean Intermittent Self Catheterization in a Neurological and no Neurological Population With Indication to Self Catheterization.
Study Start Date : March 2013
Actual Primary Completion Date : March 2015
Actual Study Completion Date : March 2015

Arm Intervention/treatment
Patients with dysvoiding function and chronic urinary retention, with an indication to CISC.
Behavioral: Intermittent catheterization test
I-CAT will be a self assessment questionnaire and a simple, comprehensive and quickly passed questionnaire.

Primary Outcome Measures :
  1. Intermittent catheterization acceptance test (I-CAT) [ Time Frame: 2 years ]

    In order to validate the questionnaire, the patients will have to respond to I-CAT at 3 times:

    • the day the CISC's indication is decided
    • at the learning'CISC consultation about 8 days later
    • during the verification's CISC consultation about 15 days later

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient diagnosed with neurological disease (brain, trauma and no trauma spinal injury, cauda equine syndrome) or non neurological disease
  • Patients seen in consultation or in traditional hospital
  • Indication for the realization of self-catheterization Intermittent must be asked because of a bladder-type retentionist or overactive bladder with an indication of medical (anticholinergics or botulinum toxin intra-detrusor injection) or surgical (kind of expansion enterocystoplasty) treatment to prevent bladder emptying without urinary catheterization
  • PP-Test score ≥10/15
  • Age > 18 years
  • Patient with social security

Exclusion Criteria:

  • Urethral injury preventing the practice of self-catheterization
  • Indication to installing a suprapubic catheter or probe
  • Patients able to answer to questionnaire and communicate in French

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01651546

Layout table for location information
Service Neuro-Urologie
Paris, France, 75012
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Layout table for investigator information
Principal Investigator: Gérard Amarenco, PU/PH Assistance Publique
Layout table for additonal information
Responsible Party: Assistance Publique - Hôpitaux de Paris Identifier: NCT01651546    
Other Study ID Numbers: NI11029
AOM 11014 ( Other Identifier: Assistance Publique )
First Posted: July 27, 2012    Key Record Dates
Last Update Posted: June 15, 2015
Last Verified: June 2015
Keywords provided by Assistance Publique - Hôpitaux de Paris:
Clean Intermittent Self Catheterization